• Please log in or register to access this feature.

Original Articles

How much phenotypic variation can be attributed to parkin genotype?

  1. Ebba Lohmann MD1,
  2. Magali Periquet BS1,
  3. Vincenzo Bonifati MD2,
  4. Nick W. Wood MD, PhD, FRCP3,
  5. Giuseppe De Michele MD4,
  6. Anne-Marie Bonnet MD5,
  7. Valérie Fraix MD6,
  8. Emmanuel Broussolle MD7,
  9. Martin W. I. M. Horstink MD8,
  10. Marie Vidailhet MD1,9,
  11. Patrice Verpillat MD, PhD1,10,
  12. Thomas Gasser MD11,
  13. David Nicholl MRCP12,
  14. Hélio Teive MD13,
  15. Salmo Raskin MD14,
  16. Olivier Rascol MD, PhD15,
  17. Alain Destée MD16,
  18. Merle Ruberg MD1,
  19. Francesca Gasparini MD1,
  20. Giuseppe Meco MD2,
  21. Yves Agid MD, PhD1,5,
  22. Alexandra Durr MD, PhD1,17,
  23. Alexis Brice MD1,5,17,*

Article first published online: 30 MAY 2003

DOI: 10.1002/ana.10613

Issue

Annals of Neurology

Annals of Neurology

Volume 54, Issue 2, pages 176–185, August 2003

Additional Information

How to Cite

Lohmann, E., Periquet, M., Bonifati, V., Wood, N. W., De Michele, G., Bonnet, A.-M., Fraix, V., Broussolle, E., Horstink, M. W. I. M., Vidailhet, M., Verpillat, P., Gasser, T., Nicholl, D., Teive, H., Raskin, S., Rascol, O., Destée, A., Ruberg, M., Gasparini, F., Meco, G., Agid, Y., Durr, A. and Brice, A. (2003), How much phenotypic variation can be attributed to parkin genotype?. Ann Neurol., 54: 176–185. doi: 10.1002/ana.10613

Author Information

  1. 1

    INSERM U289, Hôpital de la Salpêtrière, Paris, France

  2. 2

    Department of Neurological Sciences, “La Sapienza” University, Rome, Italy

  3. 3

    Department of Clinical Neurology, Institute of Neurology and National Hospital for Neurology, London, United Kingdom

  4. 4

    Dipartimento di Scienze Neurologiche, Università Federico II, Napoli, Italy

  5. 5

    Fédération de Neurologie, Hôpital de la Salpêtrière, Paris

  6. 6

    Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, France

  7. 7

    Service de Neurologie, Hôpital Neurologique Pierre Wertheimer, Lyon Monchat, France

  8. 8

    Department of Neurology, University Medical Centre, Nijmegen, The Netherlands

  9. 9

    Service de Neurologie, Hôpital Saint Antoine, Paris, France

  10. 10

    Département d 'Epidémiologie, de Biostatistique et de Recherche Clinique, Hôpital Bichat-Claude Bernard, Paris, France

  11. 11

    Neurologische Klinik Grosshadern, Ludwig-Maximilians-Universität, Münich, Germany

  12. 12

    Department of Clinical Neurology, Queen Elizabeth Hospital, Birmingham, United Kingdom

  13. 13

    Movement Disorders Unit, Neurology Service, Hospital de Clinicas, Federal University of Parana, Brazil

  14. 14

    Centro de Aconselhamento e Laboratorio Genetika, Alameda Augusto Stellfeld, Curitiba, Parana, Brazil

  15. 15

    Department of Clinical Pharmacology, Clinical Investigation Center, INSERM U455, Toulouse University Hospital

  16. 16

    Université de Lille II, Neurologie A, Clinique Neurologique, Hôpital Roger Salengro, Lille, France

  17. 17

    Département de Génétique, Cytogénétique et Embryologie, Hôpital de la Salpêtrière, Paris, France

*INSERM U289, Hôpital de la Salpêtrière, 47 Boulevard de l'Hôpital, 75013 Paris, France

  1. Members of the French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease are listed in the †.

Publication History

  1. Issue published online: 25 JUL 2003
  2. Article first published online: 30 MAY 2003
  3. Manuscript Accepted: 1 APR 2003
  4. Manuscript Revised: 7 MAR 2003
  5. Manuscript Received: 22 NOV 2002

Funded by

  • Association France-Parkinson
  • European Community Biomed 2. Grant Number: BMHCT960664
  • AVENTIS-PHARMA
  • National Institute of Health. Grant Number: NS41723-01A1
  • INSERM and Ministère de la Recherche. Grant Number: 4CH03G
  • Italian Ministry for University and Scientific and Technological Research

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (194K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

View Full Article (HTML) Get PDF (194K)